When columnist Betty Vertin falls ill after a busy week, she discovers that everything can still manage to function without her.

Patrick Moeschen is a retired middle school music teacher and nonprofit advocate. Patrick lives with limb-girdle 2E muscular ...

Biotech company Epicrispr raised $90 million to support late-stage clinical testing of EPI-321, its epigenetic treatment for ...

Accessibility in public transportation is about more than just getting where you need to go, writes columnist.

A U.S. biopharmaceutical company is gearing up to launch its first clinical trial of a novel cell therapy designed to restore lost muscle cells in people with Duchenne muscular dystrophy (DMD).

A mouse study suggests the immune response triggered by persistent muscle leakage may contribute to damage in muscular ...

My regular readers know I’ve been losing function in my right arm, making many activities of daily living challenging. The pain, weakness, and stiffness I experience when I try to do anything with ...

Despite his early frustration with checkups, columnist Patrick Moeschen eventually realized their importance for both him and ...

Columnist Betty Vertin and her family spend a week on a lake with another DMD family, and calls it a perfect end to the summer.

I’ve heard some version of that sentence hundreds of times. The diagnosis may be different, but the emotions are often the same: fear, uncertainty, grief, and a feeling that life has suddenly changed ...